| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10428194.2012.729057 |
| P698 | PubMed publication ID | 23088794 |
| P50 | author | Kristina Forsterová | Q55221939 |
| Lucia Masarova | Q88691886 | ||
| P2093 | author name string | Jiri Mayer | |
| Lucie Buresova | |||
| Zdenek Racil | |||
| Petr Cetkovsky | |||
| Iva Kocmanova | |||
| Elena Tothova | |||
| Tomas Guman | |||
| Martina Toskova | |||
| Shira Timilsina | |||
| Lubos Drgona | |||
| Eva Bojtarova | |||
| Jan Haber | |||
| Michal Kouba | |||
| Barbora Ziakova | |||
| Julia Gabzdilova | |||
| Monika Rolencova | |||
| P2860 | cites work | Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study | Q33800526 |
| Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection. | Q33876645 | ||
| Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis | Q34006585 | ||
| Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america | Q34160380 | ||
| Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ | Q37164067 | ||
| Antifungal treatment strategies in high risk patients | Q37249823 | ||
| Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy | Q37873552 | ||
| Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis. | Q38373957 | ||
| Efficacy and safety of micafungin as an empirical antifungal therapy for suspected fungal infection in neutropenic patients with hematological disorders | Q40313049 | ||
| Efficacy and safety of micafungin for treating febrile neutropenia in hematological malignancies. | Q40347435 | ||
| Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. | Q40395042 | ||
| Efficacy and safety of micafungin in febrile neutropenic patients treated for hematological malignancies. | Q40460841 | ||
| Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: analysis of results from the Caspofungin Empirical Therapy Study. | Q40481007 | ||
| Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia | Q40524745 | ||
| Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients. | Q40561901 | ||
| Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia | Q40847963 | ||
| An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients | Q43258660 | ||
| Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders | Q43468516 | ||
| Empiric versus preemptive therapy in the management of febrile neutropenia in the patient being treated for hematologic malignancy | Q43834926 | ||
| Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. | Q44059632 | ||
| European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update | Q46050924 | ||
| Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis. | Q51187346 | ||
| Current role of echinocandins in the management of invasive aspergillosis. | Q53217028 | ||
| Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis | Q53458650 | ||
| P433 | issue | 5 | |
| P921 | main subject | multicenter clinical trial | Q6934595 |
| P304 | page(s) | 1042-1047 | |
| P577 | publication date | 2012-11-15 | |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | Micafungin as empirical antifungal therapy in hematological patients: a retrospective, multicenter study in the Czech and Slovak Republics | |
| P478 | volume | 54 |
| Q36722762 | A Quasi-Experimental Study Analyzing the Effectiveness of Portable High-Efficiency Particulate Absorption Filters in Preventing Infections in Hematology Patients during Construction |
| Q40790252 | Micafungin in invasive fungal infections in children with acute leukemia or undergoing stem cell transplantation. |
| Q39416431 | Successful treatment of pulmonary candidiasis and aspergillosis in patient with refractory Hodgkin lymphoma using micafungin - case study and brief literature review |
Search more.